Back to top anchor

Vascular risk equity for all New Zealanders

Year:
2021
Duration:
60 months
Approved budget:
$4,999,920.55
Researchers:
Professor Rodney Jackson
,
Associate Professor Susan Wells
,
Associate Professor Matire Harwood
,
Professor Dr Sue Crengle
,
Dr Katrina Poppe
,
Professor Thomas Lumley
,
Dr Vanessa Selak
,
Dr Jamie-Lee Rahiri
,
Dr Romana Pylypchuk
,
Dr Claris Chung
,
Dr Corina Grey
,
Mrs Julie Winter-Smith
,
Dr Monique Jonas
,
Professor Nicola Dalbeth
,
Ms Catherine Choi
,
Dr Jinfeng Zhao
Health issue:
Cardiovascular/cerebrovascular
Proposal type:
Programme
Lay summary
Cardiovascular and associated metabolic conditions are major preventable causes of health-expectancy gaps, particularly for Māori and Pacific people. Combined population-level and individualised interventions can halve cardiovascular-metabolic risk. We have already developed and implemented cardiovascular risk prediction algorithms so New Zealand clinicians and policymakers can target at-risk patients and populations. We will now establish the VAREANZ Register, which will include up-to-date anonymised cardiovascular-metabolic risk information on every adult New Zealander, and establish sub-registers for cardiovascular-metabolic conditions responsible for significant equity gaps (diabetes, gout, obesity, heart failure and atrial fibrillation). We will risk assess each person to identify individual-level and population-level cardiovascular-metabolic risk management equity gaps nationwide. We will facilitate improvements in risk management equity by developing direct pathways to share actionable evidence with patients, providers and policymakers. A data science expert group will provide advanced statistical and artificial intelligence methodological support. The programme will be governed by a Māori-led, equity-focused data sovereignty group, overseeing all research.